Lymphadenopathy CT scan

Jump to navigation Jump to search

Lymphadenopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphadenopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphadenopathy CT scan On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphadenopathy CT scan

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphadenopathy CT scan

CDC on Lymphadenopathy CT scan

Lymphadenopathy CT scan in the news

Blogs on Lymphadenopathy CT scan

Directions to Hospitals Treating Lymphadenopathy

Risk calculators and risk factors for Lymphadenopathy CT scan

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2] Ogechukwu Hannah Nnabude, MD

Overview

A chest CT scan may be helpful in the diagnosis of hilar adenopathy. Findings on CT scan diagnostic of tuberculosis, sarcoidosis, lymphoma, and other malignancies. Abdominal and pelvic CT scan in combination with chest CT scan can be revealed in cases of supraclavicular adenopathy and the diagnosis of secondary neoplasm.

CT scan

  • CT scan may be helpful in the diagnosis of lymphadenopathy. Findings on CT scan suggestive of lymphadenopathy include:[1][2][3][4]
  • The upper limit in the size of a normal node varies with location.


PET/CT scan

  • On PET/CT scan, lymphadenopathy can be further assessed via quantitation of FDG uptake, which is a surrogate of metabolic activity. Infectious, inflammatory, and neoplastic processes will show high FDG avidity. PET/CT is particularly useful for assessing the response of lymph nodes to systemic chemotherapy.

References

  1. Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
  2. Lymph node enlargment. Radiopedia. http://radiopaedia.org/articles/lymph-node-enlargement Accessed on May 9, 2016
  3. van den Brekel MW, Castelijns JA (January 2000). "Imaging of lymph nodes in the neck". Semin Roentgenol. 35 (1): 42–53. PMID 10670052.
  4. Sumi M, Ohki M, Nakamura T (April 2001). "Comparison of sonography and CT for differentiating benign from malignant cervical lymph nodes in patients with squamous cell carcinoma of the head and neck". AJR Am J Roentgenol. 176 (4): 1019–24. doi:10.2214/ajr.176.4.1761019. PMID 11264102.

Template:WH Template:WS